Literature DB >> 29384026

Evaluation of an Academic-Community Partnership to Implement MTM Services in Rural Communities to Improve Pharmaceutical Care for Patients with Diabetes and/or Hypertension.

Melissa Johnson1, Rebecca Jastrzab2, Jared Tate3, Kate Johnson1, Elizabeth Hall-Lipsy3, Rose Martin4, Ann M Taylor3, Terri Warholak3.   

Abstract

BACKGROUND: Although the current methods of medication therapy management (MTM) delivery have demonstrably improved therapeutic, safety, economic, and humanistic health outcomes, patient- and prescriber-level barriers persist, limiting its reach and effectiveness.
OBJECTIVE: To assess telephonic- and community-based clinical pharmacy services in improving health indicators for rural, underserved patients.
METHODS: In 2014, an established MTM provider created a novel, collaborative pilot program with independent retail and community health center pharmacies to provide comprehensive, telephonic MTM services to rural Arizonans. This pilot program used a combined telephonic- and community-based pharmacist approach in the provision of MTM services for rural, underserved Arizona populations. Adults with diabetes mellitus and/or hypertension, seen by a prescriber or who filled prescriptions at a contracted, rural facility in 2014, were eligible to participate. Initial MTM telephonic consultations were conducted, and recommendations were communicated to patients' prescribers and/or pharmacists. Patients received a follow-up telephone call at standard intervals, depending on risk severity.
RESULTS: A total of 517 patients participated, and 237 medication-related and 1,102 health promotion interventions were completed. Positive trends were observed in fasting blood glucose, postprandial glucose, and diastolic blood pressure. Broad variation in prescriber acceptance of pharmacist recommendations was observed (27%-60%).
CONCLUSIONS: Study results provide initial evidence to support the efficacy of collaborative efforts in the provision of MTM services for improving health indicators and safety measures while potentially reducing health care disparities. While the results are encouraging, future research is warranted in more diverse populations and settings. DISCLOSURES: This work was supported in part by funding from the Centers for Disease Control and Prevention via a multiyear, interagency grant from the Arizona Department of Health Services. The findings and conclusions presented in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention nor the Arizona Department of Health Services. Study concept and design were contributed by M. Johnson, Jastrzab, Hall-Lipsy, Martin, and Warholak. M. Johnson took the lead in data collection, along with K. Johnson, Martin, Jastrzab, and Hall-Lipsy. Data interpretation was performed by Jastrzab, Warholak, and Taylor. The manuscript was written by K. Johnson, M. Johnson, and Jastrzab, along with the other authors, and revised by M. Johnson, Tate, and Taylor, along with Jastrzab, K. Johnson, and Hall-Lipsy. The data from this manuscript were previously presented in poster and podium format by Jastrzab and Johnson at the American Public Health Annual Meeting; Chicago, Illinois; October 31-November 4, 2015.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29384026     DOI: 10.18553/jmcp.2018.24.2.132

Source DB:  PubMed          Journal:  J Manag Care Spec Pharm


  6 in total

1.  Pharmacy students' attitudes and perceptions toward pharmacogenomics education.

Authors:  Shanice Coriolan; Nimota Arikawe; Arden Moscati; Lisheng Zhou; Stephanie Dym; Seda Donmez; Adinoyi Garba; Sasha Falbaum; Zvi Loewy; Melinda Lull; Maha Saad; Jane Shtaynberg; Aniwaa Owusu Obeng
Journal:  Am J Health Syst Pharm       Date:  2019-05-17       Impact factor: 2.637

2.  Implementation process for comprehensive medication review in the community pharmacy setting.

Authors:  Chelsea Phillips Renfro; Kea Turner; Raj Desai; Jacob Counts; Christopher M Shea; Stefanie P Ferreri
Journal:  J Am Pharm Assoc (2003)       Date:  2019-08-09

3.  The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta.

Authors:  Leigh Ann Ross; Lauren S Bloodworth; Meagan A Brown; Scott S Malinowski; Rebecca Crane; Victor Sutton; Masoumeh Karimi; A Cassandra Dove Brown; Thomas Dobbs; Lisle Hites
Journal:  Prev Chronic Dis       Date:  2020-09-17       Impact factor: 2.830

4.  Implementation of a medication adherence program in senior public housing facilities utilizing pharmacists and health educators.

Authors:  Kimberly Pounds; Dominique Guinn; Ivy O Poon; Aisha Morris Moultry
Journal:  Arch Community Med Public Health       Date:  2020-11-05

Review 5.  Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States.

Authors:  Jean-Venable Goode; James Owen; Alexis Page; Sharon Gatewood
Journal:  Pharmacy (Basel)       Date:  2019-08-04

6.  Impact evaluation of a four-year academic-community partnership in provision of medication management and tertiary prevention services for rural patients with diabetes and/or hypertension.

Authors:  Elizabeth J Anderson; David Rhys Axon; Ann M Taylor; Victoria Towers; Terri Warholak; Melissa Johnson; Stephanie Forbes; Teresa Manygoats
Journal:  Prev Med Rep       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.